Cerebral infarction following intravenous immunoglobulin therapy for Guillain-Barre syndrome

Intravenous immunoglobulin (IVIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndrome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment with intravenous immunoglobulin for Guillain-Ba...

Full description

Saved in:
Bibliographic Details
Published in:Journal of stroke and cerebrovascular diseases 2001-11, Vol.10 (6), p.290-292
Main Authors: Velioğlu, Sibel K., Özmenoğlu, Mehmet, Boz, Cavit
Format: Article
Language:English
Subjects:
cerebral infarction
Guillain-Barre syndrome
intravenous immunoglobulin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intravenous immunoglobulin (IVIg) therapy is used increasingly for different immune-mediated diseases, such as the Guillain-Barre syndrome. We report the case of a 55-year-old man who developed a cerebral infarction 2 days after completion of treatment with intravenous immunoglobulin for Guillain-Barre syndrome. Copyright © 2001 by National Stroke Association
ISSN:1052-3057
1532-8511
DOI:10.1053/jscd.2001.123772